Faster ApprovalsFaster, predictable, and globally aligned clinical trial approvals are critical for India to attract high-value research and strengthen scientific capability and capacityPatrick JohnsonExecutive Vice President of Eli Lilly and Company and Pres…
India must step up and actively pursue accelerated regulatory review pathways without sacrificing the quality, said Patrick Johnson, executive vice president of Eli Lilly and Company and President of… [+3613 chars]
